The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Diabetes
NCT ID: NCT06826703
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
64 participants
INTERVENTIONAL
2025-02-15
2025-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing With Diabetes Patients
NCT05187806
The Effect of Motivational Interviewing on Diabetes Self-Management in Diabetic Patients
NCT06727123
Motivational Interviewing on Self-Care Activities in T2DM: The Sample of Turkey
NCT05544435
The Effect of Motivational Interviewing on Self-Efficacy and Quality of Life in Gestational Diabetes Mellitus
NCT06243939
Mobile Technology and Motivational Interviewing in Type 2 Diabetes Patients
NCT05919706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group receiving diabetes education with motivational interviewing technique based on health belief m
Patient Introduction Form, Diabetes Self-Management Scale (DSMS), Cyberchondria Severity Scale-Short Form (CSS-SS-SF) scales will be applied to the experimental group before the training. Then, individuals in the experimental group will be given diabetes education one day a week with the motivational interviewing technique based on the health belief model. A total of 4 weeks of education will be given. After the end of the training, Patient Introduction Form, Diabetes Self-Management Scale (DMSS), Cyberchondria Severity Scale-Short Form (SCS-SF) scales will be applied.
Experimental Group
Individuals will receive diabetes education with motivational interviewing technique based on health belief model.
group who did not receive diabetes education with motivational interviewing technique
Patient introduction form, Diabetes Self-Management Scale (DMSMS), Cyberchondria Severity Scale-Short Form (CSS-SS-SF) scales will be applied to the control group at the first encounter. After 1 month, the Patient Introduction Form, Diabetes Self-Management Scale (DMSS), Cyberchondria Severity Scale-Short Form (CSS-SF) scales will be applied again. No application will be made to the control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Group
Individuals will receive diabetes education with motivational interviewing technique based on health belief model.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being over 18 years old
* To have sufficient communication skills to answer verbal and written questions and fulfill instructions
* Being literate
* No physical, cognitive or mental impairment in answering the questions
* Willingness to participate in research.
Exclusion Criteria
* Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process
* The emergence of any health problem that prevents the person from continuing the research
* Do not leave the study voluntarily.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülşen Altuntas Çalım
health services teacher in the ministry of national education
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Van Regional Training and Research Hospital Diabetes Polyclinic
Van, Van, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AU-SBF-GAÇ-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.